功能化银纳米颗粒作为多功能剂对抗肠道微生物群失衡和炎症
Mihaela Stoyanova1, Vera Gledacheva2, Miglena Milusheva1,3
1Department of Organic Chemistry, Faculty of Chemistry, University of Plovdiv, 4000 Plovdiv, Bulgaria.
Nanomaterials (Basel, Switzerland)
|June 11, 2025
概括
含有药物的银纳米粒子 (AgNPs) 显示出强大的抗微生物和抗真菌作用. 这些AgNP还保持抗炎和解活性,表明对肠道和肝脏疾病的治疗潜力.
科学领域:
- 纳米技术纳米技术
- 菌类学 菌类学是指菌类学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 人类致病真菌会引起各种感染.
- 纳米粒子 (NP) 作为抗真菌剂提供了一个有前途的方法.
- 梅贝维林类似物 (MA) 是胃肠道问题的潜在药物候选者.
研究的目的:
- 评估含有药物装载银纳米颗粒 (AgNPs) 携带美贝类型 (MA) 的抗微生物和抗真菌作用.
- 评估这些AgNP的抗炎,抗微生物和抗活性.
- 研究AgNP对肝细胞形态和增殖的影响.
主要方法:
- 密度函数理论 (DFT) 计算用于机制识别.
- 在体外和体外对抗炎和解作用的评估.
- 针对各种真菌和细菌菌株进行体外抗菌试验.
- 对肝细胞形态和增殖的评估.
主要成果:
- 药物装载的AgNPs显示出对测试的真菌菌株 (黑色菌,黑色菌,形菌,白菌,大脑菌) 有望的抗真菌活性.
- 观察到良好的抗微生物活性对抗阳性和阴性细菌.
- AgNPs保留了MA的抗炎和解作用,减少了炎症.
- 肝细胞形态和增殖受到影响,表明治疗潜力.
结论:
- 含有药物的AgNP是潜在的抗菌剂.
- 这些AgNP保持了MA的解和抗炎性质.
- 进一步的体内和临床前研究是有必要的,以确定治疗疗效.
相关概念视频
Bacterial Flora of the Large Intestine
399
The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
399
Drugs for Treatment of Ulcerative Colitis in IBD
130
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
130
Inflammatory Bowel Disease IV: Pharmacological Management
118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
118


